Pak & Švehelka / Blog / Healthcare Law

Advance directives: consent to — or refusal of — treatment given in advance

Advance directives: consent to — or refusal of — treatment given in advance

Modern medicine can save life even where once there was no hope — and at the same time it can prolong life in situations where it is questionable whether that is truly in the patient's interest. Where a patient is unable to express their will, decisions about treatment become highly sensitive both ethically and legally. The advance directive allows consent to, or refusal of, treatment to be expressed in advance.

The advance directive is set out in Section 36 of the Health Services Act. Its original five-year validity was struck down by the Constitutional Court — today a directive is not limited in time. It must be in writing with an officially certified signature and must include the doctor's advice to the patient on the consequences of such a decision.

The wording is crucial. It must define precisely the situations the directive covers and the specific medical measures concerned — artificial nutrition, resuscitation attempts, respiratory support, hospitalisation. The provider is obliged to respect the directive where the patient cannot express their will, the provider has the directive available and the anticipated situation has arisen. Conversely, a directive cannot require the active causing of death or endanger other people.

We recommend combining the advance directive with a preliminary declaration under Section 38 of the Civil Code — the designated person can then inform the provider of the directive and insist on its being respected on the patient's behalf. We will gladly help you prepare such a document.

View the original piece — Právní prostor →

MUDr. Mgr. Mario Švehelka
About the author

MUDr. Mgr. Mario Švehelka

A doctor and a lawyer in one. He graduated from the Faculty of General Medicine at Charles University in 1988, qualified as a specialist in internal medicine in 1991 and for many years headed the research department of the Prague branch of the pharmaceutical company Eli Lilly. He completed the Faculty of Law at Palacký University in Olomouc in 2006.

Profile →

Have a questionon this topic?

Need advice? Get in touch with us.